GlassScriptPhysician profile
Keith W Norman
NPI 1992144331
$4,112.08
in general payments reported to CMS, 2019-2025
22 companies · $596 in 2025
The $596 reported for 2025 was more than what 78% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $777 · 2022: $1,589 · 2023: $417 · 2024: $733 · 2025: $596.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,746.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,746.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $773.31 | 2022 | |
| Biosense Webster, INC. | $384.92 | 2021-2022 | |
| Gilead Sciences, INC. | $317.31 | 2022-2023 | Epclusa |
| Abbvie INC. | $254.04 | 2021-2022 | |
| Coloplast Corp | $241.33 | 2023-2025 | Titan |
| Neurocrine Biosciences, INC. | $225.88 | 2021-2024 | Ingrezza |
| Regeneron Healthcare Solutions, INC. | $224.42 | 2023-2024 | Dupixent |
| Genzyme Corporation | $199.08 | 2021-2022 | |
| Boston Scientific Corporation | $185.33 | 2021-2025 | Embold Fibered |
| Sage Therapeutics, LLC | $180.03 | 2024-2025 | |
| Viiv Healthcare Company | $121.49 | 2021 | |
| Astellas Pharma US INC | $115.77 | 2024 | Veozah |
| Medtronic, INC. | $111.03 | 2022 | |
| Noven Pharmaceuticals, INC. | $106.87 | 2024 | Xelstrym |
| Idorsia Pharmaceuticals US INC | $103.84 | 2023 | Quviviq |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $97.46 | 2021 | |
| Edwards Lifesciences Corporation | $95.60 | 2025 | Sapien 3 Ultra Resilia |
| Amgen INC. | $95.46 | 2025 | Krystexxa |
| Janssen Pharmaceuticals, INC | $95.39 | 2024 | Spravato |
| Astrazeneca Pharmaceuticals LP | $95.05 | 2024 | Airsupra |
| Lundbeck LLC | $50.00 | 2022 | |
| Exact Sciences Corporation | $38.47 | 2024-2025 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Norman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.